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Case report
40
A case of tacrolimus-induced encephalopathy after 
kidney transplantation
We present a case of tacrolimus-induced encephalopathy after 
successful kidney transplantation. An 11-year-old girl presented with 
sudden onset of neurologic symptoms, hypertension, and psychiatric 
symptoms, with normal kidney function, after kidney transplantation. 
The symptoms improved after cessation of tacrolimus. Magnetic 
resonance imaging (MRI) showed acute infarction of the middle 
cerebral artery (MCA) territory in the right frontal lobe. Three days 
later, she had normal mental function and maintained normal blood 
pressure with left hemiparesis. Follow-up MRI was performed on 
D19, showing new infarct lesions at both cerebral hemispheres. Ten 
days later, MRI showed further improvement, but brain single photon 
emission computed tomography (SPECT) showed mild reduction 
of uptake in both the anterior cingulate gyrus and the left thalamus. 
One month after onset of symptoms, angiography showed complete 
resolution of stenosis. However, presenting as a mild fine motor 
disability of both hands and mild dysarthria, what had been atrophy 
at both centrum semiovale at 4 months now showed progression 
to encephalomalacia. There are two points of interest in this case. 
First, encephalopathy occurred after administration of tacrolimus and 
improved after discontinuation of the drug. Second, the development 
of right-side hemiplegia could not be explained by conventional 
MRI; but through diffusion tensor imaging (DTI) and diffusion tensor 
tractography (DTT) of white matter tract, visualization was possible.
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Introduction
 Cyclosporin A and tacrolimus are important immunosuppressant 
drugs used to prevent rejection of transplanted organs or bone marrow
1). 
However, development of posterior reversible encephalophathy 
syndrome (PRES) is commonly seen in association with cyclosporin 
A and tacrolimus after transplantation
1). PRES is a relatively new 
clinicoradiological entity first described as reversible posterior leu-
koencephalopathy syndrome in 1996, characterized by head  aches, 
altered mental status, seizures, and visual loss. Clinical neuroimaging Korean J Pediatr 2011;54(1):40-45 • DOI: 10.3345/kjp.2011.54.1.40    41
shows edema involving the white matter in the posterior portions of 
the cerebral hemispheres, especially bilaterally in the parieto-occipital 
regions
2, 3). Prompt recognition is vital, as most patients will experience 
complete recovery by reduction of drug dosage or by withholding 
the immunosuppressive agent altogether
4). Symptomatology and 
characteristic MRI features of this clinicoradiological entity have 
been reported, but it still is poorly understood by pediatricians
5-11). 
Here, we present a case of tacrolimus-induced encephalopathy which 
was visualized through diffuson-tensor tractography.
Case report
An eleven-year old girl has had chronic renal insufficiency since 
her neonatal period. She was born premature at 32 weeks gestation, 
diagnosed with renal hypoplasia, hypocalcemia, neonatal sepsis, 
urinary tract infection, acute renal failure, and atrial septal defect 
during neonatal period. She has been under conservative treatment 
(erythropoietin, angiotensin-converting enzyme (ACE) inhibitors, 
and calcium) without dialysis since then. At the age of 11 years, 
she received kidney transplantation from her mother, a preemptive 
living related donor kidney. There were two HLA-B, and HLA-DR 
mismatches but ABO-identity (O positive). Immunosuppression 
included tacrolimus (0.1 mg/kg/day, bid), mycophenolate mofetil 
(600 mg/m
2, bid), and prednisolone (0.5 mg/kg qd). Postoperatively, 
her renal function was good without acute rejection.
On day 12 after transplantation, sudden onset of left side motor 
weakness of grade 0 developed. Blood pressure was 160/100 mmHg 
and consequently, antihypertensive drugs were administered.
Brain magnetic resonance imaging (MRI) and angiography (MRA) 
showed acute infarction at right frontal lobe of middle cerebral artery 
territory (Fig. 1, 2). Other laboratory findings were normal, including 
serum creatinine of 0.69 mg/dL. Serum tacrolimus level was 9 ng/
mL. On day 13, psychiatric symptoms such as irritability, mood 
instability, aggressive behavior, and dysarthria developed, diagnosed 
as adjustment disorder, antipsychotics medication started. Within 
few days, psychotic symptoms improved.
On day 19, mentality and blood pressure were restored, with slight 
improvement of left hemiparesis of grade 1 to 2. Follow-up MRI was 
taken after some clinical improvement, showing new infarct lesions 
at both cerebral hemispheres. Tacrolimus dose was reduced. But 
with no recognizable clinical response even after decreased serum 
concentration, it was replaced by cyclosporine.
On day 29, her renal function was normal, and her blood 
pressure was normotensive. Brain single photon emission computed 
Fig. 1. High-signal intensity at right frontal lobe affecting mainly white matter in T2-weighted images on 
day 12, was bright on diffusion-weighted images and low-intensity on ADC maps, consistent with cytotoxic 
edema, suggesting acute cerebral infarction (arrows).
Fig. 2. Angiography showed severe stenosis at both anterior (ACA) and middle cerebral arteries (MCA), with 
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tomography (SPECT) (Fig. 3) and tensor MRI for diffusion tensor 
tractography (DTT) (Fig. 4) were performed. The patient went under 
comprehensive rehabilitation. Tensor MRI showed improving status 
of multifocal infarcts at both cerebral hemispheres. SPECT showed 
reduction of perfusion in both cingulate gyrus and left thalamus.
On day 42, improvement of left side hemiparesis was noted, and 
follow-up MRA showed improvement of cerebral artery stenosis.
On day 56, the patient was discharged from hospital, with 
improvement of left hand function, and gait disturbance.
At four months after transplantation, increased dysarthria, along 
with right hand tremor and clumsiness were noted. Tensor MRI 
showed atrophy at both centrum semiovale, with progression to 
encephalomalacia. There were no further aggravations during follow-
up.
Discussion
Causative agents of PRES include immunosuppressives such as 
tacrolimus, cyclosporine, cisplatin, and erythropoietin, with the 
condition manifesting in such presentations as preeclampsia and 
eclampsia, acute glomerulonephritis, thrombotic thrombocytopenic 
purpura, and hemolytic uremic syndrome
4). Severe hypertension 
with autoregulatory failure and forced hyperperfusion remains to be 
widely accepted
1).
 The key pathophysiological process of this syndrome was identified 
as vasogenic edema
2, 12, 13). A breakdown in cerebral autoregulation 
results in the leakage of fluid into the interststium, which is detected 
as vasogenic edema. In patients with PRES, myogenic response is 
blunted by either passive overdistension of the vessels due to elevations 
in blood pressure or direct toxic effects on the endothelium
4). The 
abnormalities primarily affect white matter but the cortex can also 
be involved
4). The posterior cerebral hemispheres are susceptible to 
the neurotoxicity of calcineurin inhibitors, especially the occipital 
lobes
7). The posterior circulation is most vulnerable because of poor 
sympathetic innervation. Diffusion-weighted imaging (DWI) has 
been shown to be reliable in distinguishing vasogenic edema from 
cytotoxic edema
4, 14).
The mechanism by which calcineurin inhibitors lead to neuro-
toxicity remains poorly understood. Both cyclosporine and tacrolimus 
decreased endothelial cell viability and increased permeability, which 
is consistent with impaired function of the blood-brain barrier. Both 
drugs inhibit P-glycoprotein, which could lead to enhanced brain 
distribution of theses drugs and neurotoxicity
7). The encephalopathy 
associated with tacrolimus is multifactorial in origin. Known factors 
include changes in intracellular urea concentration in the brain, fluid 
overload, high blood levels of tacrolimus/cyclosporine, and inadequate 
blood pressure control
7).
 PRES clinically presents with seizures, severe headaches, and 
mental and visual changes
15). Risk factors include hypertension and 
calcineurin inhibitor administration, fluid retention, renal failure, and 
alteration in vascular permeability
2). Discontinuation of tacrolimus 
may be considered as diagnostic tool, if symptoms persist or other 
complications warrant this approach
16).
Differential diagnosis of PRES has been reported as ischemic 
stroke, cerebral venous thrombosis, intracranial vasculitis, progressive 
multifocal leukoencephalopathy, X-linked adrenoleukodystrophy, 
acute disseminated encephalomyelitis, encephalitis caused by 
electrolyte disturbance, and encephalopathy of unknown origin
2).
Of the imaging modalities, MRI is most sensitive diagnostic 
study, and is preferred tool than CT. It is more accurate for diagnosis 
and gives better prediction of PRES outcomes. DWI and apparent 
diffusion coefficient (ADC) maps can reliably differentiate the 
changes from cytotoxic edema
4). Typical findings show high signal 
intensity mainly in subcortical white matter in the posterior parietal 
and occipital lobes in T2-weighted and FLAIR sequences, whereas 
atypical findings show involvement of gray matter, frontal lobes, 
thalamus, brainstem, and cerebellum as well as restricted diffusion 
Fig. 3. Mild reduction of uptake in both anterior cingulate gyrus and left 
thalamus.
Fig. 4. Diffusion tensor tractography (DTT) on day 29 shows 
discontinuation of right corticospinal tract (CST) at cortex (arrow); and 
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on DWI (cytotoxic edema). At MRA, moderate to severe vessel 
irregularity consistent with vasoconstriction and vasodilation has 
been described in most patients, with reversal of vasoconstriction and 
vasodilation in nearly all patients
4).
 Catheter angiography, MRA and MR perfusion (MRP) de-
monstrate evidence of vasculopathy with focal and diffuse vaso-
constriction, vasodilatation, and a string-of-bead pattern along with 
reduced relative cerebral blood volume in PRES patients
1).
 Brain SPECT shows the underlying cerebral blood flow and 
consequently metabolic activity patterns of the brain. 
 Diffusion tensor imaging (DTI) is a recently developed technique 
by virtue of its ability to visualize water diffusion characteristics and 
very useful to evaluate the extent of the fiber damage in diseases that 
affect the white matter. DTT, derived from DTI, allows for three-
dimensional visualization of the architecture and integrity of the 
white matter tract at the subcortical level. DTT is more sensitive 
to explain the character of white matter lesions which cannot be 
explained by conventional MRI
22-24).
Rigorous and meticulous control of blood pressure is mandatory 
for successful treatment. Using various antihypertensive drugs, 
nicardipine is effective to limit blood pressure promptly with 
less fluctuation
2, 17). Cessation of calcineurin inhibitor use is a 
key component. Most were reversible by reducing the dosage or 
withholding the drugs, but some reports showed successful control 
without cessation
2).
 Symptomatic treatment measures and antipsychotic medication 
for possible psychotic stages, as in this case, may be needed. Also, 
aggressive, comprehensive early rehabilitation improves prognostic 
outcomes.
The prognosis of PRES generally accepted as benign, except with 
intracranial hemorrhage. Recurrence is rare, but prolonged seizures, 
hypertension, or both may result in permanent neurological deficit 
and cerebral infarction
2, 8, 18). If the intervention is not done in a 
timely manner, the functional vasogenic brain edema may convert to 
cytotoxic brain edema, giving permanent sequelae
15).
 This case, after tacrolimus adminstration, presenting with sudden 
onset of neurologic symptoms, hypertension, and psychiatric 
symptoms showed improvement after cessation of tacrolimus 
and blood pressure control. Conventional MRI showed ischemic 
infarction, which could not explain the development of right-sided 
hemiplegia. However, using DTI, visualization was possible through 
DTT of white matter tract.
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